Extracorporeal Membrane Oxygenation Machine Market by Modality, Application and Region - Analysis & Forecasts to 2021

  • ID: 4085027
  • Report
  • Region: Global
  • 131 Pages
  • Markets and Markets
1 of 5
The Global Extracorporeal Membrane Oxygenation Machine Market is Expected to Reach USD 305.3 Million by 2021 from USD 247.2 Million in 2016 at a CAGR of 4.3%

FEATURED COMPANIES

  • Alung Technologies, Inc.
  • Eurosets S.R.L.
  • Getinge Group
  • Livanova PLC
  • Medtronic PLC
  • Nipro Corporation
  • MORE

The extracorporeal membrane oxygenation (ECMO) machine market is poised to reach USD 305.3 million by 2021 from USD 247.2 million in 2016, at a CAGR of 4.3%. Factors such as growing cardiovascular and respiratory diseases, rising adoption of ECMO as a bridge to lung transplantation, growing number of ECMO centers, conferences and training programs to increase awareness, and technological advancements have led to the growth of the market.
 
On the basis of modality, the market is segmented into venoarterial (VA), venovenous (VV), and arteriovenous (AV). The venovenous (VV) segment is expected to account for the largest share of the market in 2016. The large share of this segment is mainly attributed to the high incidence of respiratory failure, rising lung transplants, and technological advancements. The arteriovenous (AV) segment is projected to grow at the highest CAGR in the forecast period.
 
Based on application, the respiratory segment is expected to account for the largest share of the market, in 2016. The large share of this segment is mainly attributed to factors such as rising incidence of respiratory failure, lung cancer, growing lung transplants, and increasing adoption of ECMO systems.

North America is expected to account for the largest share of the global market in 2016, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). The large share of the North American region can be attributed to the favorable reimbursement scenario, the rising incidence of lung cancer, and the presence of a large number of ECMO centers in the U.S.

The Asia-Pacific region is expected to witness the highest growth rate in the forecast period, mainly due to the favorable reimbursement scenario in Japan, the rising cardiovascular diseases in China, the growing application and adoption of ECMO in India, and the rising cardiopulmonary disorders in Australia.

The market witnesses high competitive intensity, as there are several big and small firms with similar product offerings. These companies adopt various strategies (approvals, product launches, agreements & partnerships, expansions, rebranding, acquisitions, website launches, product deployments, and market development) to increase their market shares and establish a stronger foothold in the global market.

Research Coverage:

This report studies the ECMO machine market based on modality, application, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help them, garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies to strengthen their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the ECMO machine market. The report analyzes the market based on modality, application, and region.
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the ECMO machine market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various Extracorporeal Membrane Oxygenation (ECMO) products across regions.
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the ECMO machine market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the ECMO machine market
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Alung Technologies, Inc.
  • Eurosets S.R.L.
  • Getinge Group
  • Livanova PLC
  • Medtronic PLC
  • Nipro Corporation
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Insights From Primary Sources
2.2.2.3 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Market Data Validation and Triangulation
2.5 Assumptions for the Study

3 Executive Summary
3.1 Introduction
3.2 Conclusion

4 Premium Insights
4.1 Extracorporeal Membrane Oxygenation (ECMO) Machine: Market Overview
4.2 Geographic Analysis: ECMO Machine Market, By Modality (2016)
4.3 ECMO Machine Market, By Application, 2016 vs 2021
4.4 Geographic Snapshot of the ECMO Machine Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Prevalence of Cardiovascular and Respiratory Diseases
5.2.1.2 Growing Adoption of ECMO in Lung Transplantation Procedures
5.2.1.3 Growth in the Number of ECMO Centers
5.2.1.4 Technological Advancements in ECMO Machine
5.2.2 Restraints
5.2.2.1 Complications Associated With ECMO
5.2.2.2 High Cost of ECMO Procedures
5.2.3 Opportunities
5.2.3.1 Increasing Survival Rates With ECMO
5.2.4 Challenges
5.2.4.1 Lack of Skilled Professionals

6 Global Extracorporeal Membrane Oxygenation Machine Market, By Modality
6.1 Introduction
6.2 Venovenous ECMO
6.3 Venoarterial ECMO
6.4 Arteriovenous ECMO

7 Global Extracorporeal Membrane Oxygenation Machine Market, By Application
7.1 Introduction
7.2 Respiratory Applications
7.2.1 Neonates
7.2.2 Pediatrics
7.2.3 Adults
7.3 Cardiac Applications
7.3.1 Adults
7.3.2 Pediatrics
7.3.3 Neonates
7.4 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
7.4.1 Neonates
7.4.2 Pediatrics
7.4.3 Adults

8 Extracorporeal Membrane Oxygenation Machine Market, By Region
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.1.1 Rising Healthcare Spending
8.2.1.2 Rise in Geriatric Population, Prevalence of Cardiovascular Diseases
8.2.1.3 Increase in Research Studies
8.2.2 Canada
8.2.2.1 Implementation of A New Funding Model in Canadian Hospitals
8.2.2.2 Conferences to Increase Awareness
8.3 Europe
8.3.1 Germany
8.3.1.1 Increasing Volume of ECMO Procedures in Germany
8.3.2 U.K.
8.3.2.1 Rising Adoption of ECMO Procedures
8.3.3 France
8.3.3.1 Rising Healthcare Spending
8.3.4 Rest of Europe
8.3.4.1 Decreasing Number of Cardiovascular Deaths in Spain
8.3.4.2 Rising Risk of Diseases in Sweden
8.4 Asia-Pacific
8.4.1 Japan
8.4.1.1 Favorable Reimbursement Scenario
8.4.2 China
8.4.2.1 Rising Geriatric Population, Cvd Prevalence
8.4.3 India
8.4.3.1 Growing Applications and Rising Adoption of ECMO
8.4.4 Rest of Asia-Pacific
8.4.4.1 Prevalence of Cardiovascular and Respiratory Diseases in Australia
8.5 Rest of the World
8.5.1 Rising Adoption of ECMO as A Bridge to Heart and Lung Transplantation in Brazil
8.5.2 Conferences in UAE to Increase Awareness

9 Competitive Landscape
9.1 Overview
9.2 Market Share Analysis
9.2.1 Getinge Group
9.2.2 Medtronic PLC
9.2.3 Livanova PLC
9.3 Competitive Situation and Trends
9.3.1 Approvals
9.3.2 Product Launches
9.3.3 Agreements & Partnerships
9.3.4 Expansions
9.3.5 Other Strategies

10 Company Profiles
(Company at A Glance, Recent Financials, Products & Services, Strategies & Insights, & Recent Developments)*
10.1 Introduction
10.2 Getinge Group
10.3 Medtronic PLC
10.4 Livanova PLC
10.5 Terumo Corporation
10.6 Xenios AG (Acquired By Fresenius Medical Care AG & Co. KGaA)
10.7 Microport Scientific Corporation
10.8 Nipro Corporation
10.9 Origen Biomedical, Inc.
10.10 Alung Technologies, Inc.
10.11 Eurosets S.R.L.

*Details on Company at A Glance, Recent Financials, Products & Services, Strategies & Insights, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.

11 Appendix
11.1 Discussion Guide
11.2 Other Developments
11.2.1 Livanova PLC
11.2.2 Xenios AG (Acquired By Fresenius Medical Care AG & Co. KGaA)
11.2.3 Alung Technologies, Inc.

List of Tables

Table 1 Average Cost of Extracorporeal Membrane Oxygenation Machine in Various Countries
Table 2 Indicative List of Training Programs for ECMO By Hospitals
Table 3 Extracorporeal Membrane Oxygenation Machine Market Size, By Modality, 2014-2021 (USD Million)
Table 4 Venovenous ECMO Machine Market Size, By Region, 2014-2021 (USD Million)
Table 5 North America: Venovenous ECMO Machine Market Size, By Country, 2014-2021 (USD Million)
Table 6 Europe: Venovenous ECMO Machine Market Size, By Country/Region, 2014-2021 (USD Million)
Table 7 Asia-Pacific: Venovenous ECMO Machine Market Size, By Country/Region, 2014-2021 (USD Million)
Table 8 Venoarterial ECMO Machine Market Size, By Region, 2014-2021 (USD Million)
Table 9 North America: Venoarterial ECMO Machine Market Size, By Country, 2014-2021 (USD Million)
Table 10 Europe: Venoarterial Extracorporeal Membrane Oxygenation Machine Market Size, By Country/Region, 2014-2021 (USD Million)
Table 11 Asia-Pacific: Venoarterial ECMO Machine Market Size, By Country/Region, 2014-2021 (USD Million)
Table 12 Arteriovenous ECMO Machine Market Size, By Region, 2014-2021 (USD Million)
Table 13 North America: Arteriovenous ECMO Machine Market Size, By Country, 2014-2021 (USD Million)
Table 14 Europe: Arteriovenous ECMO Machine Market Size, By Country, 2014-2021 (USD Million)
Table 15 Asia-Pacific: Arteriovenous ECMO Machine Market Size, By Country/Region, 2014-2021 (USD Million)
Table 16 Extracorporeal Membrane Oxygenation Machine Market Size, By Application, 2014-2021 (USD Million)
Table 17 Extracorporeal Membrane Oxygenation Machine Market Size for Respiratory Applications, By Region, 2014-2021 (USD Million)
Table 18 North America: ECMO Machine Market Size for Respiratory Applications, By Country , 2014-2021 (USD Million)
Table 19 Europe: ECMO Machine Market Size for Respiratory Applications, By Region, 2014-2021 (USD Million)
Table 20 Asia-Pacific: Extracorporeal Membrane Oxygenation Machine Market Size for Respiratory Applications, By Region, 2014-2021 (USD Million)
Table 21 ECMO Machine Market Size for Respiratory Applications, By Type, 2014-2021 (USD Million)
Table 22 Neonates Receiving ECMO Support for Respiratory Applications
Table 23 Pediatric Patients Receiving ECMO Support for Respiratory Applications
Table 24 Lung Transplants in Adults ( Between January 1995 and June 2015)
Table 25 Adults Receiving ECMO Support for Respiratory Applications
Table 26 ECMO Machine Market Size for Cardiac Applications, By Region, 2014-2021 (USD Million)
Table 27 North America: Extracorporeal Membrane Oxygenation Machine Market Size for Cardiac Applications, By Country, 2014-2021 (USD Million)
Table 28 Europe: ECMO Machine Market for Cardiac Applications, By Country/Region, 2014-2021 (USD Million)
Table 29 Asia-Pacific: Extracorporeal Membrane Oxygenation Machine Market Size for Cardiac Applications, By Country/Region, 2014-2021 (USD Million)
Table 30 Extracorporeal Membrane Oxygenation Machine Market Size for Cardiac Applications, By Type, 2014-2021 (USD Million)
Table 31 Adults Receiving ECMO Support for Cardiac Applications
Table 32 Pediatric Patients Receiving ECMO Support for Cardiac Applications
Table 33 Neonates Receiving ECMO Support for Cardiac Applications
Table 34 ECMO Machine Market Size for ECPR Applications, By Region, 2014-2021 (USD Million)
Table 35 North America: ECMO Machine Market Size for ECPR Applications, By Country, 2014-2021 (USD Million)
Table 36 Europe: Extracorporeal Membrane Oxygenation Machine Market Size for ECPR Applications, By Country/Region, 2014-2021 (USD Million)
Table 37 Asia-Pacific: ECMO Machine Market Size for ECPR Applications, By Country/Region, 2014-2021 (USD Million)
Table 38 ECMO Market Size for ECPR Applications, By Type, 2014-2021 (USD Million)
Table 39 ECMO Machine Market Size, By Region, 2014-2021 (USD Million)
Table 40 North America: ECMO Machine Market Size, By Country, 2014-2021 (USD Million)
Table 41 North America: Extracorporeal Membrane Oxygenation Machine Market Size, By Modality, 2014-2021 (USD Million)
Table 42 North America: ECMO Machine Market Size, By Application, 2014-2021 (USD Million)
Table 43 Indicative List of Research Articles Published in the U.S.
Table 44 U.S.: Extracorporeal Membrane Oxygenation Machine Market Size, By Modality, 2014-2021 (USD Million)
Table 45 U.S.: ECMO Machine Market Size, By Application, 2014-2021 (USD Million)
Table 46 Canada: Extracorporeal Membrane Oxygenation Machine Market Size, By Modality, 2014-2021 (USD Million)
Table 47 Canada: ECMO Machine Market Size, By Application, 2014-2021 (USD Million)
Table 48 Europe: ECMO Machine Market Size, By Country, 2014-2021 (USD Million)
Table 49 Europe: Extracorporeal Membrane Oxygenation Machine Market Size, By Modality, 2014-2021 (USD Million)
Table 50 Europe: ECMO Machine Market Size, By Application, 2014-2021 (USD Million)
Table 51 Germany: ECMO Machine Market Size, By Modality, 2014-2021 (USD Million)
Table 52 Germany: Extracorporeal Membrane Oxygenation Machine Market Size, By Application, 2014-2021 (USD Million)
Table 53 U.K.: ECMO Machine Market Size, By Modality, 2014-2021 (USD Million)
Table 54 U.K.: Extracorporeal Membrane Oxygenation Machine Market Size, By Application, 2014-2021 (USD Million)
Table 55 France: ECMO Machine Market Size, By Modality, 2014-2021 (USD Million)
Table 56 France: ECMO Machine Market Size, By Application, 2014-2021 (USD Million)
Table 57 RoE: Extracorporeal Membrane Oxygenation Machine Market Size, By Modality, 2014-2021 (USD Million)
Table 58 RoE: ECMO Machine Market Size, By Application, 2014-2021 (USD Million)
Table 59 Asia-Pacific: Extracorporeal Membrane Oxygenation Machine Market Size, By Country, 2014-2021 (USD Million)
Table 60 Asia-Pacific: ECMO Machine Market Size, By Modality, 2014-2021 (USD Million)
Table 61 Asia-Pacific: ECMO Machine Market Size, By Application, 2014-2021 (USD Million)
Table 62 Japan: ECMO Machine Market Size, By Modality, 2014-2021 (USD Million)
Table 63 Japan: Extracorporeal Membrane Oxygenation Machine Market Size, By Application, 2014-2021 (USD Million)
Table 64 China: ECMO Machine Market Size, By Modality, 2014-2021 (USD Million)
Table 65 China: ECMO Machine Market Size, By Application, 2014-2021 (USD Million)
Table 66 Indicative List of Hospitals Providing ECMO Treatment
Table 67 India: Extracorporeal Membrane Oxygenation Machine Market Size, By Modality, 2014-2021 (USD Million)
Table 68 India: ECMO Machine Market Size, By Application, 2014-2021 (USD Million)
Table 69 RoAPAC: ECMO Machine Market Size, By Modality, 2014-2021 (USD Million)
Table 70 RoAPAC: Extracorporeal Membrane Oxygenation Machine Market Size, By Application, 2014-2021 (USD Million)
Table 71 Indicative List of Conferences Related to ECMO
Table 72 RoW: ECMO Machine Market Size, By Modality, 2014-2021 (USD Million)
Table 73 RoW: ECMO Machine Market Size, By Application, 2014-2021 (USD Million)
Table 74 Approvals, 2013-2016
Table 75 Product Launches, 2013-2016
Table 76 Agreements & Partnerships, 2013-2016
Table 77 Expansions, 2013-2016
Table 78 Other Strategies, 2013-2016

List of Figures

Figure 1 ECMO Machine Market Segmentation
Figure 2 Extracorporeal Membrane Oxygenation (ECMO) Machine Market: Research Methodology Steps
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Research Design
Figure 6 Data Triangulation Methodology
Figure 7 Venovenous Segment Dominates the ECMO Machine Market, By Modality, in 2016
Figure 8 Respiratory Applications Segment Accounts for the Largest Share of the ECMO Machine Market in 2016
Figure 9 Asia-Pacific to Register the Highest CAGR During the Forecast Period
Figure 10 Asia-Pacific Offers Significant Growth Opportunities for Players in the ECMO Machine Market
Figure 11 Venovenous Segment to Dominate the ECMO Machine Market in 2016
Figure 12 Respiratory Applications Will Continue to Dominate the ECMO Machine Market in 2021
Figure 13 Asia-Pacific to Register the Highest CAGR During the Forecast Period
Figure 14 Extracorporeal Membrane Oxygenation (ECMO) Machine Market: Drivers, Restraints, Opportunities, and Challenges
Figure 15 Number of Deaths From Cardiovascular and Respiratory Diseases Across the Globe, 2000 vs 2012 (Thousand Individuals)
Figure 16 Global Increase in the Number of ECMO Centers
Figure 17 North America to Command the Largest Share of the Market in 2016
Figure 18 North America: Market Snapshot
Figure 19 Europe: Market Snapshot
Figure 20 Asia-Pacific: Market Snapshot
Figure 21 Rest of the World (RoW): Market Snapshot
Figure 22 ECMO Machine Market Share, By Key Player, 2015
Figure 23 Key Developments in the ECMO Machine Market, 2013-2016
Figure 24 Battle for Market Share: Product Approvals Accounted for the Largest Share of the Total Developments Registered Between 2013 & 2016
Figure 25 Geographic Revenue Mix of the Prominent Players in the ECMO Machine Market
Figure 26 Getinge Group: Company Snapshot (2015)
Figure 27 Medtronic PLC: Company Snapshot (2015)
Figure 28 Livanova PLC: Company Snapshot (2014)
Figure 29 Terumo Corporation: Company Snapshot (2015)
Figure 30 Microport Scientific Corporation: Company Snapshot (2015)
Figure 31 Nipro Corporation: Company Snapshot (2015)

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Alung Technologies, Inc.
  • Eurosets S.R.L.
  • Getinge Group
  • Livanova PLC
  • Medtronic PLC
  • Nipro Corporation
  • MORE

The global extracorporeal membrane oxygenation (ECMO) machine market is expected to reach USD 305.3 Million by 2021 from USD 247.2 Million in 2016, at a CAGR of 4.3%.

The global market is segmented on the basis of modality, application, and region. By modality, the market is segmented into venoarterial (VA), venovenous (VV), and arteriovenous (AV). The venovenous (VV) segment is accounted for the largest share of the market in 2016. The large share of this segment is mainly attributed to the high incidence of respiratory failure, rising lung transplants, increasing incidence of COPD, and technological advancements. The arteriovenous (AV) segment is projected to grow at the highest CAGR in the forecast period.

Based on application, the market is segmented into respiratory, cardiac, and extracorporeal cardiopulmonary resuscitation (ECPR). The respiratory segment is estimated to grow at the highest CAGR in the forecast period, due to factors such as the rising incidence of respiratory failure, lung cancer, and lung transplants, growing ECMO centers, and the increasing adoption of ECMO in hospitals.

On the basis of region, the global market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2016, North America accounted for the largest share of the global market, followed by Europe, Asia-Pacific, and the Rest of the World. The Asia-Pacific market is expected to grow at the highest CAGR and serve as a revenue pocket for companies offering ECMO systems. Moreover, the growth is attributed to factors such as growing cardiovascular and respiratory diseases, rising adoption of ECMO as a bridge to lung transplantation, growing number of ECMO centers, conferences & training programs to increase awareness, and technological advancements.

A majority of the leading players in the market is focusing on approvals, product launches, agreements, partnerships, expansions, and acquisitions to expand their product portfolios and customer bases, enhance their sales channels, and increase their global presence.

In 2015, the market was dominated by Getinge Group (Sweden), Medtronic plc (Ireland), and LivaNova PLC (U.K.). The other players in the market are XENIOS AG (Germany), Terumo Corporation (Japan), MicroPort Scientific Corporation (China), NIPRO Corporation (Japan), OriGen Biomedical, Inc. (U.S.), ALung Technologies, Inc. (Germany), and EUROSETS S.r.l. (Italy).

Note: Product cover images may vary from those shown
5 of 5
  • Alung Technologies, Inc.
  • Eurosets S.R.L.
  • Getinge Group
  • Livanova PLC
  • Medtronic PLC
  • Microport Scientific Corporation
  • Nipro Corporation
  • Origen Biomedical, Inc.
  • Terumo Corporation
  • Xenios AG (Acquired By Fresenius Medical Care AG & Co. KGaA)
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll